Achilles Tendinopathy Pathogenesis and Management: A Narrative Review †

Int J Environ Res Public Health · 2023 · Italy

Source and licence

Authors
Domiziano Tarantino, Rosita Mottola, Giuseppina Resta et al.
Title
Achilles Tendinopathy Pathogenesis and Management: A Narrative Review †
Journal
International Journal of Environmental Research and Public Health, 2023
Licence
CC BY 4.0
Changes
Verbatim excerpts; formatting adapted

Full text retrieved 2026-10-27 from Europe PMC · PMC10487940

Licence statement of the original publication

Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).

This page reproduces excerpts of the original publication; the original is authoritative. It has not been reviewed by a physician, does not state a recommendation of Medelix and does not replace medical advice. The guideline may have been updated since.

Open the original publication →Full text on Europe PMC

Abstract

The Achilles tendon is the thickest and strongest tendon of the human body, and it is frequently injured during sports activity. The incidence of Achilles tendon pathologies has increased over recent decades, especially in the last few years, because of increased sports participation among the general population and due to the diffusion of competitive sports at a high level. Tendinopathies are common in athletes and in middle-aged overweight patients. The term “tendinopathy” refers to a condition characterised clinically by pain and swelling, with functional limitations of tendon and nearby structures, and consequently to chronic failure of healing response process. Tendinopathies can produce marked morbidity, and at present, scientifically validated management modalities are limited. Despite the constantly increasing interest and number of studies about Achilles tendinopathy (AT), there is still not a consensual point of view on which is the best treatment, and its management is still controversial. AT can be treated conservatively primarily, with acceptable results and clinical outcomes. When this approach fails, surgery should be considered. Several surgical procedures have been described for both conditions with a relatively high rate of success with few complications and the decision for treatment in patients with AT should be tailored on patient’s needs and level of activity. The aim of this article is to give insights about the pathogenesis and most used and recent treatment options for AT.

Contents of the original publication

The section headings of the original.

  • 1. Introduction
  • 2. Methods
  • 3. Discussion
  • 3.1. Pathogenesis
  • 3.2. Management Options
  • 3.3. Conservative Treatment
  • 3.4. Surgical Treatment
  • 3.5. Use of Stem Cells: Where Are We?
  • 3.6. Limitations
  • 4. Conclusions
  • Institutional Review Board Statement
  • Informed Consent Statement

A question about this guideline?

Medelix answers clinical questions from guidelines and studies – every statement with its source.

Are you the rights holder and object to this reproduction? Write to contact@medelix.ai and we will take the page down promptly. Imprint